Published: June 2017 | Report Code: 11380 | Available Format: PDF | Pages: 108
Chapter 1. Research Background
1.1 Research Objectives
1.2 Market Definition
1.3 Research Scope
1.3.1 Market Segmentation by Type
1.3.2 Market Segmentation by Application
1.3.3 Market Segmentation by Geography
1.3.4 Analysis Period
1.3.5 Market Data Reporting Unit
1.3.5.1 Value
1.4 Key Stakeholders
Chapter 2. Research Methodology
2.1 Secondary Research
2.2 Primary Research
2.2.1 Breakdown of Primary Research Respondents
2.2.1.1 By region
2.2.1.2 By industry participant
2.2.1.3 By company type
2.3 Market Size Estimation
2.4 Data Triangulation
2.5 Assumptions for the Study
Chapter 3. Executive Summary
Chapter 4. Introduction
4.1 Definition of Market Segments
4.1.1 By Type
4.1.1.1 Passive
4.1.1.1.1 Matrix systems
4.1.1.1.2 Reservoir systems
4.1.1.2 Active
4.1.1.2.1 Electrical based
4.1.1.2.1.1 Iontophoresis
4.1.1.2.1.2 Electroporation
4.1.1.2.1.3 Sonophoresis
4.1.1.2.2 Structure based
4.1.1.2.3 Others
4.1.2 By Application
4.1.2.1 Analgesics
4.1.2.2 Hormone replacement therapy
4.1.2.3 Smoking cessation
4.1.2.4 Hypertension
4.1.2.5 Motion sickness
4.1.2.6 Others
4.2 Market Dynamics
4.2.1 Drivers
4.2.1.1 Increasing adoption of advanced transdermal delivery systems
4.2.1.2 Rising prevalence of chronic disorders
4.2.1.3 Growing geriatric population
4.2.1.4 Impact analysis of drivers on market forecast
4.2.2 Restraints
4.2.2.1 Drawbacks associated with transdermal delivery systems
4.2.2.2 Impact analysis of restraints on market forecast
4.2.3 Opportunities
4.2.3.1 Lucrative opportunities in emerging economies
Chapter 5. Global Market Size and Forecast
5.1 By Type
5.1.1 Passive Systems by Type
5.1.2 Active Systems by Type
5.1.2.1 Electrical based active systems by modality
5.2 By Application
5.3 By Region
Chapter 6. North America Market Size and Forecast
6.1 By Type
6.1.1 Passive Systems by Type
6.1.2 Active Systems by Type
6.1.2.1 Electrical based active systems by modality
6.2 By Application
6.3 By Country
Chapter 7. Europe Market Size and Forecast
7.1 By Type
7.1.1 Passive Systems by Type
7.1.2 Active Systems by Type
7.1.2.1 Electrical based active systems by modality
7.2 By Application
7.3 By Country
Chapter 8. APAC Market Size and Forecast
8.1 By Type
8.1.1 Passive Systems by Type
8.1.2 Active Systems by Type
8.1.2.1 Electrical based active systems by modality
8.2 By Application
8.3 By Country
Chapter 9. LAMEA Market Size and Forecast
9.1 By Type
9.1.1 Passive Systems by Type
9.1.2 Active Systems by Type
9.1.2.1 Electrical based active systems by modality
9.2 By Application
9.3 By Country
Chapter 10. Competitive Landscape
10.1 Market Share Analysis of Key Players
Chapter 11. Company Profiles
11.1 Novartis AG
11.1.1 Business Overview
11.1.2 Product and Service Offerings
11.2 Johnson & Johnson
11.2.1 Business Overview
11.2.2 Product and Service Offerings
11.3 Mylan N.V.
11.3.1 Business Overview
11.3.2 Product and Service Offerings
11.4 Boehringer Ingelheim GmbH
11.4.1 Business Overview
11.4.2 Product and Service Offerings
11.5 Bayer AG
11.5.1 Business Overview
11.5.2 Product and Service Offerings
11.6 Purdue Pharma L.P.
11.6.1 Business Overview
11.6.2 Product and Service Offerings
11.7 GlaxoSmith Kline plc
11.7.1 Business Overview
11.7.2 Product and Service Offerings
11.8 3M Company
11.8.1 Business Overview
11.8.2 Product and Service Offerings
11.9 Echo Therapeutics Inc.
11.9.1 Business Overview
11.9.2 Product and Service Offerings
11.1 Endo International plc
11.10.1 Business Overview
11.10.2 Product and Service Offerings
Chapter 12. Appendix
12.1 Abbreviations
12.2 Sources and References
12.3 Related Reports
LIST OF TABLES
TABLE 1 ANALYSIS PERIOD OF THE STUDY
TABLE 2 DRIVERS FOR THE MARKET: IMPACT ANALYSIS
TABLE 3 RESTRAINTS FOR THE MARKET: IMPACT ANALYSIS
TABLE 4 GLOBAL TRANSDERMAL DRUG DELIVERY SYSTEMS MARKET, BY TYPE, $M (2016–2023)
TABLE 5 GLOBAL PASSIVE TRANSDERMAL DRUG DELIVERY SYSTEMS MARKET, BY TYPE, $M (2016–2023)
TABLE 6 GLOBAL ACTIVE TRANSDERMAL DRUG DELIVERY SYSTEMS MARKET, BY TYPE, $M (2016–2023)
TABLE 7 GLOBAL ELECTRICAL BASED ACTIVE TRANSDERMAL DRUG DELIVERY SYSTEMS MARKET, BY MODALITY, $M (2016–2023)
TABLE 8 GLOBAL TRANSDERMAL DRUG DELIVERY SYSTEMS MARKET, BY APPLICATION, $M (2016–2023)
TABLE 9 GLOBAL TRANSDERMAL DRUG DELIVERY SYSTEMS MARKET, BY REGION, $M (2016–2023)
TABLE 10 NORTH AMERICA TRANSDERMAL DRUG DELIVERY SYSTEMS MARKET, BY TYPE, $M (2016–2023)
TABLE 11 NORTH AMERICA PASSIVE TRANSDERMAL DRUG DELIVERY SYSTEMS MARKET, BY TYPE, $M (2016–2023)
TABLE 12 NORTH AMERICA ACTIVE TRANSDERMAL DRUG DELIVERY SYSTEMS MARKET, BY TYPE, $M (2016–2023)
TABLE 13 NORTH AMERICA ELECTRICAL BASED ACTIVE TRANSDERMAL DRUG DELIVERY SYSTEMS MARKET, BY MODALITY, $M (2016–2023)
TABLE 14 NORTH AMERICA TRANSDERMAL DRUG DELIVERY SYSTEMS MARKET, BY APPLICATION, $M (2016–2023)
TABLE 15 NORTH AMERICA TRANSDERMAL DRUG DELIVERY SYSTEMS MARKET, BY COUNTRY, $M (2016–2023)
TABLE 16 EUROPE TRANSDERMAL DRUG DELIVERY SYSTEMS MARKET, BY TYPE, $M (2016–2023)
TABLE 17 EUROPE PASSIVE TRANSDERMAL DRUG DELIVERY SYSTEMS MARKET, BY TYPE, $M (2016–2023)
TABLE 18 EUROPE ACTIVE TRANSDERMAL DRUG DELIVERY SYSTEMS MARKET, BY TYPE, $M (2016–2023)
TABLE 19 EUROPE ELECTRICAL BASED ACTIVE TRANSDERMAL DRUG DELIVERY SYSTEMS MARKET, BY MODALITY, $M (2016–2023)
TABLE 20 EUROPE TRANSDERMAL DRUG DELIVERY SYSTEMS MARKET, BY APPLICATION, $M (2016–2023)
TABLE 21 EUROPE TRANSDERMAL DRUG DELIVERY SYSTEMS MARKET, BY COUNTRY, $M (2016–2023)
TABLE 22 APAC TRANSDERMAL DRUG DELIVERY SYSTEMS MARKET, BY TYPE, $M (2016–2023)
TABLE 23 APAC PASSIVE TRANSDERMAL DRUG DELIVERY SYSTEMS MARKET, BY TYPE, $M (2016–2023)
TABLE 24 APAC ACTIVE TRANSDERMAL DRUG DELIVERY SYSTEMS MARKET, BY TYPE, $M (2016–2023)
TABLE 25 APAC ELECTRICAL BASED ACTIVE TRANSDERMAL DRUG DELIVERY SYSTEMS MARKET, BY MODALITY, $M (2016–2023)
TABLE 26 APAC TRANSDERMAL DRUG DELIVERY SYSTEMS MARKET, BY APPLICATION, $M (2016–2023)
TABLE 27 APAC TRANSDERMAL DRUG DELIVERY SYSTEMS MARKET, BY COUNTRY, $M (2016–2023)
TABLE 28 LAMEA TRANSDERMAL DRUG DELIVERY SYSTEMS MARKET, BY TYPE, $M (2016–2023)
TABLE 29 LAMEA PASSIVE TRANSDERMAL DRUG DELIVERY SYSTEMS MARKET, BY TYPE, $M (2016–2023)
TABLE 30 LAMEA ACTIVE TRANSDERMAL DRUG DELIVERY SYSTEMS MARKET, BY TYPE, $M (2016–2023)
TABLE 31 LAMEA ELECTRICAL BASED ACTIVE TRANSDERMAL DRUG DELIVERY SYSTEMS MARKET, BY MODALITY, $M (2016–2023)
TABLE 32 LAMEA TRANSDERMAL DRUG DELIVERY SYSTEMS MARKET, BY APPLICATION, $M (2016–2023)
TABLE 33 LAMEA TRANSDERMAL DRUG DELIVERY SYSTEMS MARKET, BY COUNTRY, $M (2016–2023)
TABLE 34 NOVARTIS AG – AT A GLANCE
TABLE 35 JOHNSON & JOHNSON - AT A GLANCE
TABLE 36 MYLAN N.V. – AT A GLANCE
TABLE 37 BOEHRINGER INGELHEIM GMBH – AT A GLANCE
TABLE 38 BAYER AG – AT A GLANCE
TABLE 39 PURDUE PHARMA L.P. – AT A GLANCE
TABLE 40 GLAXOSMITH KLINE PLC – AT A GLANCE
TABLE 41 3M COMPANY – AT A GLANCE
TABLE 42 ECHO THERAPEUTICS INC. – AT A GLANCE
TABLE 43 ENDO INTERNATIONAL PLC – AT A GLANCE
LIST OF FIGURES
FIG 1 RESEARCH SCOPE
FIG 2 RESEARCH METHODOLOGY
FIG 3 REGIONAL SPLIT OF PRIMARY AND SECONDARY RESEARCH
FIG 4 BREAKDOWN OF PRIMARY RESEARCH BY REGION
FIG 5 BREAKDOWN OF PRIMARY RESEARCH BY INDUSTRY PARTICIPANT
FIG 6 BREAKDOWN OF PRIMARY RESEARCH BY COMPANY TYPE
FIG 7 DATA TRIANGULATION APPROACH
FIG 8 GLOBAL TRANSDERMAL DRUG DELIVERY SYSTEMS MARKET SUMMARY
FIG 9 AGING POPULATION AS A PERCENTAGE OF TOTAL POPULATION
FIG 10 SNAPSHOT OF GLOBAL TRANSDERMAL DRUG DELIVERY SYSTEMS MARKET, BY TYPE (2016)
FIG 11 GLOBAL TRANSDERMAL DRUG DELIVERY SYSTEMS MARKET, BY TYPE, $M (2016–2023)
FIG 12 GLOBAL PASSIVE TRANSDERMAL DRUG DELIVERY SYSTEMS MARKET, BY TYPE, $M (2016–2023)
FIG 13 GLOBAL ACTIVE TRANSDERMAL DRUG DELIVERY SYSTEMS MARKET, BY TYPE, $M (2016–2023)
FIG 14 GLOBAL ELECTRICAL BASED ACTIVE TRANSDERMAL DRUG DELIVERY SYSTEMS MARKET, BY MODALITY, $M (2016–2023)
FIG 15 GLOBAL TRANSDERMAL DRUG DELIVERY SYSTEMS MARKET, BY APPLICATION, $M (2016–2023)
FIG 16 WORLDWIDE MAJOR MARKETS FOR TRANSDERMAL DRUG DELIVERY SYSTEMS
FIG 17 NORTH AMERICA TRANSDERMAL DRUG DELIVERY SYSTEMS MARKET SNAPSHOT
FIG 18 NORTH AMERICA TRANSDERMAL DRUG DELIVERY SYSTEMS MARKET, BY TYPE, $M (2016–2023)
FIG 19 NORTH AMERICA PASSIVE TRANSDERMAL DRUG DELIVERY SYSTEMS MARKET, BY TYPE, $M (2016–2023)
FIG 20 NORTH AMERICA ACTIVE TRANSDERMAL DRUG DELIVERY SYSTEMS MARKET, BY TYPE, $M (2016–2023)
FIG 21 NORTH AMERICA ELECTRICAL BASED ACTIVE TRANSDERMAL DRUG DELIVERY SYSTEMS MARKET, BY MODALITY, $M (2016–2023)
FIG 22 NORTH AMERICA TRANSDERMAL DRUG DELIVERY SYSTEMS MARKET, BY APPLICATION, $M (2016–2023)
FIG 23 NORTH AMERICA TRANSDERMAL DRUG DELIVERY SYSTEMS MARKET, BY COUNTRY, $M (2016–2023)
FIG 24 EUROPE TRANSDERMAL DRUG DELIVERY SYSTMES MARKET SNAPSHOT
FIG 25 EUROPE TRANSDERMAL DRUG DELIVERY SYSTEMS MARKET, BY TYPE, $M (2016–2023)
FIG 26 EUROPE PASSIVE TRANSDERMAL DRUG DELIVERY SYSTEMS MARKET, BY TYPE, $M (2016–2023)
FIG 27 EUROPE ACTIVE TRANSDERMAL DRUG DELIVERY SYSTEMS MARKET, BY TYPE, $M (2016–2023)
FIG 28 EUROPE ELECTRICAL BASED ACTIVE TRANSDERMAL DRUG DELIVERY SYSTEMS MARKET, BY MODALITY, $M (2016–2023)
FIG 29 EUROPE TRANSDERMAL DRUG DELIVERY SYSTEMS MARKET, BY APPLICATION, $M (2016–2023)
FIG 30 EUROPE TRANSDERMAL DRUG DELIVERY SYSTEMS MARKET, BY COUNTRY, $M (2016–2023)
FIG 31 APAC TRANSDERMAL DRUG DELIVERY SYSTMES MARKET SNAPSHOT
FIG 32 APAC TRANSDERMAL DRUG DELIVERY SYSTEMS MARKET, BY TYPE, $M (2016–2023)
FIG 33 APAC PASSIVE TRANSDERMAL DRUG DELIVERY SYSTEMS MARKET, BY TYPE, $M (2016–2023)
FIG 34 APAC ACTIVE TRANSDERMAL DRUG DELIVERY SYSTEMS MARKET, BY TYPE, $M (2016–2023)
FIG 35 APAC ELECTRICAL BASED ACTIVE TRANSDERMAL DRUG DELIVERY SYSTEMS MARKET, BY MODALITY, $M (2016–2023)
FIG 36 APAC TRANSDERMAL DRUG DELIVERY SYSTEMS MARKET, BY APPLICATION, $M (2016–2023)
FIG 37 APAC TRANSDERMAL DRUG DELIVERY SYSTEMS MARKET, BY COUNTRY, $M (2016–2023)
FIG 38 LAMEA TRANSDERMAL DRUG DELIVERY SYSTMES MARKET SNAPSHOT
FIG 39 LAMEA TRANSDERMAL DRUG DELIVERY SYSTEMS MARKET, BY TYPE, $M (2016–2023)
FIG 40 LAMEA PASSIVE TRANSDERMAL DRUG DELIVERY SYSTEMS MARKET, BY TYPE, $M (2016–2023)
FIG 41 LAMEA ACTIVE TRANSDERMAL DRUG DELIVERY SYSTEMS MARKET, BY TYPE, $M (2016–2023)
FIG 42 LAMEA ELECTRICAL BASED ACTIVE TRANSDERMAL DRUG DELIVERY SYSTEMS MARKET, BY MODALITY, $M (2016–2023)
FIG 43 LAMEA TRANSDERMAL DRUG DELIVERY SYSTEMS MARKET, BY APPLICATION, $M (2016–2023)
FIG 44 LAMEA TRANSDERMAL DRUG DELIVERY SYSTEMS MARKET, BY COUNTRY, $M (2016–2023)
FIG 45 GLOBAL TRANSDERMAL DRUG DELIVERY SYSTEMS MARKET SHARE OF KEY PLAYERS (2016)
Get a bespoke market intelligence solution
Want a report tailored exactly to your business strategy?
Request CustomizationWant an insight-rich discussion with the report author?
Speak to AnalystOur dedication to providing the most-accurate market information has earned us verification by Dun & Bradstreet (D&B). We strive for quality checking of the highest level to enable data-driven decision making for you
Our insights into the minutest levels of the markets, including the latest trends and competitive landscape, give you all the answers you need to take your business to new heights
With 24/7 research support, we ensure that the wheels of your business never stop turning. Don’t let time stand in your way. Get all your queries answered with a simple phone call or email, as and when required
We take a cautious approach to protecting your personal and confidential information. Trust is the strongest bond that connects us and our clients, and trust we build by complying with all international and domestic data protection and privacy laws